In 2023, the leukemia mortality rate for females in Japan was a key reference point for forecasting future trends. Between 2024 and 2028, forecasts indicate a steady increase in mortality figures, rising from 3.67 to 3.8 thousands. The annual growth rate appears moderate with year-on-year increases consistently around 0.8% to 1%. Calculating the compound annual growth rate (CAGR) over this forecasted period indicates a modest 0.7% increase per year.
Future trends to watch include advancements in medical treatments, healthcare policy changes, and the aging population's impact. Monitoring these factors will be essential for understanding deviations from current forecasts.
